4/17/2022666 White-listed Manufacturing Enterprises Including Nearly 100 Pharma...

4/16/2022Opportunities and Challenges in China for Developing Oncology Drugs fo...

4/15/2022NMPA Issues the Guidelines for Pharmacovigilance Inspections

4/15/2022Drug R&D and Product Registration News Digest April 2022 (2)

4/14/2022Lenz and Ji Xing Announce an Exclusive Greater China License Agreement

4/14/2022Bayer Receives Chinese Approval for Its Cancer Drug Vitrakvi (larotrec...

4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021

4/14/2022One to Watch: China's Cell and Gene Therapies Industry (PharmExec)

4/13/2022China Meheco to Distribute Ascletis's Ritonavir Tablets in Mainland Ch...

4/13/2022Prevalence and Risk of Atrial Fibrillation in China: A National Cross-...

4/13/2022SEC Adds Another 12 Chinese Companies to Its Watchlist under the HFCAA

4/12/2022Chinese Pharma Foreign Trade Up 1.9% in 2021 with Sharply Surging West...

4/12/2022NMPA Issues the Measures for Drug Annual Reports

4/12/2022Pfizer Wins Chinese Approval of JAK1 Inhibitor Abrocitinib for moderat...

4/11/2022Nan Fung's Pivotal bioVenture Launches $150M China-focused Biotech Fun...

4/11/2022Decentralized CRO Science 37 Expands in the Asia-Pacific including Chi...

4/11/2022India Hopes 'Pharma City' Will Break China's Grip on Industry

4/11/2022Clinical Development Strategies for Western Biotech Companies in China...

4/10/2022 Cancer Drug Maker BeiGene Takes Action to Mitigate Delisting Risk (Th...

4/10/2022Market Segmentation Snapshot of Chinese Retail Drug Market 2019-2021

4/10/2022Chinese Pharma Profits Fell Sharply in the First Two Months of 2022

4/10/2022CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...

4/8/2022Propella Enters Licensing Deal with Jiangsu Aosaikang for Development ...

4/8/2022Recent Executive Moves

4/8/2022Drug R&D and Product Registration News Digest April 2022 (1)

4/8/2022China Approves 18 New Drugs in Q1/2022 (PharmCube)

4/8/2022China Views Pay-For-Delay Deal as Antitrust Offence, Lawyer Cautions (...

4/7/2022The Chinese Pharma CMO Market to Reach $13B in 2030, Predicts Roots An...

4/7/2022Pregene, CellPoint to Co-develop anti-BCMA CAR-T Cell Therapy in Europ...

4/7/2022CDE Solicits Comments on the Draft Q&As on Research Conditions of Diss...

Page:144/775 Total number of articles:23233: [First][<<] [142] [143] [144] [145] [146] [>>] [End]